Benefits
Bone Mineral Density (Strontium Ranelate)
SOTI trial (Meunier 2004) showed strontium ranelate 2 g/day reduced vertebral fractures by 41% vs placebo over 3 years in postmenopausal osteoporosis. TROPOS trial showed reduced non-vertebral fractures. Established strontium ranelate as evidence-based osteoporosis treatment in Europe — until safety concerns led to restriction in 2014.
Dual Action — Bone Formation AND Resorption Inhibition
Distinguishes strontium from most other bone agents. Increases osteoblast (bone formation) activity AND decreases osteoclast (bone resorption) activity. Most bisphosphonates only inhibit resorption.
Strontium Citrate (Supplement) Theoretical Effects
Strontium citrate is the typical supplemental form — provides similar elemental strontium to ranelate but NOT same drug. Theoretical bone-supportive effects via similar mechanism. CRITICAL: strontium citrate lacks direct RCT evidence equivalent to ranelate; effects extrapolated from ranelate data.
DEXA Scan Artifact (False BMD Increase)
CRITICAL CONSIDERATION: strontium has higher atomic weight than calcium; even modest strontium incorporation into bone creates ARTIFACTUAL INCREASE in DEXA bone density readings (~10% per 1% strontium content). This OVERESTIMATES true bone density gains with strontium. Real bone strength gains are smaller than DEXA suggests.
Mechanism of action
Bone Matrix Incorporation
Strontium substitutes for calcium in bone hydroxyapatite — creating strontium-containing bone matrix. Mechanism similar to calcium incorporation but with different physical properties.
Calcium-Sensing Receptor Modulation
Strontium activates calcium-sensing receptor (CaSR) on osteoblasts and osteoclasts — basis for dual action on bone formation and resorption.
Osteoblast Stimulation
Increases osteoblast number, activity, and bone formation markers. Distinct from bisphosphonates which only inhibit resorption.
Osteoclast Inhibition
Reduces osteoclast differentiation and activity — decreasing bone resorption.
Clinical trials
Phase 3 RCT of strontium ranelate 2 g/day vs placebo in 1,649 postmenopausal women with osteoporosis for 3 years.
1,649 postmenopausal osteoporosis patients.
41% reduction in vertebral fracture risk vs placebo. Established strontium ranelate as evidence-based osteoporosis treatment. Foundation for European prescription approval.
Pooled analyses of strontium ranelate trials examining cardiovascular events.
Pooled trial populations.
Increased risk of myocardial infarction, venous thromboembolism. Combined with severe skin reactions (DRESS syndrome cases) led to EMA RESTRICTION in 2014 — limited to severe osteoporosis where alternatives unavailable. Eventually withdrawn from many markets.
About this ingredient
STRONTIUM is a MINERAL (atomic number 38) chemically SIMILAR to CALCIUM (both alkaline earth metals). Found naturally in soil, water, food (especially seafood, grains, vegetables grown in strontium-rich soil). DISTINCT FROM RADIOACTIVE STRONTIUM-90 (a fission product from nuclear weapons/reactors) — supplemental strontium is NON-RADIOACTIVE natural strontium-88 (and minor stable isotopes).
FORMS: (1) STRONTIUM RANELATE — prescription drug (Protelos®/Protaxos®); SOTI/TROPOS trial evidence; RESTRICTED in EU 2014 due to safety concerns; not available in US; (2) STRONTIUM CITRATE — typical supplement form; widely sold OTC; lacks direct RCT evidence; theoretical similar effects via similar mechanism; (3) STRONTIUM CARBONATE, lactate, gluconate — less common forms.
EVIDENCE-BASED USES: (1) POSTMENOPAUSAL OSTEOPOROSIS — strontium ranelate has direct RCT evidence; strontium citrate (supplement) is extrapolated; (2) Bone formation support / dual mechanism.
CRITICAL SAFETY CAUTIONS: (1) STRONTIUM RANELATE SAFETY HISTORY — EU restricted in 2014 due to: cardiovascular events (MI, VTE — especially in those with cardiovascular risk factors), severe skin reactions including DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) — life-threatening; THIS HISTORY IS RELEVANT to any strontium supplementation; (2) CARDIOVASCULAR RISK — those with: ischemic heart disease, peripheral vascular disease, cerebrovascular disease, uncontrolled hypertension, history of VTE — should AVOID strontium ranelate; theoretical concern with strontium citrate at high doses; (3) DEXA SCAN ARTIFACT — strontium's higher atomic weight than calcium creates FALSELY ELEVATED DEXA BMD readings; ~10% BMD overestimation per 1% strontium incorporation; for accurate bone density tracking, this must be considered; some practitioners use OTHER bone markers (CTX, P1NP) for monitoring during strontium use; (4) PREGNANCY/LACTATION — limited safety data; AVOID; (5) RENAL IMPAIRMENT — strontium primarily renally excreted; reduce dose with eGFR <30; AVOID with severe renal failure; (6) PHENYLKETONURIA — strontium ranelate contains aspartame (relevant for ranelate, not citrate); (7) DOSE — strontium ranelate (prescription): 2 g/day on empty stomach (away from calcium); strontium citrate (supplement): 680 mg elemental strontium typical; take SEPARATELY from calcium (2-3+ hour gap); (8) CALCIUM SEPARATION — calcium and strontium compete for absorption; supplementation timing is critical; common pattern: calcium with breakfast/lunch, strontium with dinner or bedtime; (9) STRONTIUM CITRATE VS RANELATE — the citrate form lacks direct RCT evidence but is widely used in supplements; theoretical similar effects; safety profile may differ (ranelate's cardiovascular signals may be related to ranelate-specific factors, not strontium itself, but uncertainty remains); (10) FOR OSTEOPOROSIS — bisphosphonates, denosumab, teriparatide, romosozumab have stronger direct evidence for fracture prevention with better-characterized safety; strontium is generally considered second/third-line; consult endocrinologist or rheumatologist; (11) BONE HEALTH FOUNDATION — adequate calcium, vitamin D, vitamin K2, weight-bearing exercise, protein intake are foundational regardless of any specific supplement; strontium is adjunctive at most; (12) STRONTIUM-90 distinction — ALWAYS verify supplemental strontium is from natural (non-radioactive) sources; reputable brands certify this.